| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
4D pharma plc (NASDAQ: LBPSW)
LBPSW Technical Analysis
5
| As on 29th Jun 2022 LBPSW STOCK Price closed @ 0.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.81 & Strong Sell for SHORT-TERM with Stoploss of 1.02 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LBPSWSTOCK Price
| Open | 0.04 | Change | Price | % |
| High | 0.04 | 1 Day | -0.02 | -33.33 |
| Low | 0.04 | 1 Week | -0.21 | -84.00 |
| Close | 0.04 | 1 Month | -0.29 | -87.88 |
| Volume | N/A | 1 Year | -1.72 | -97.73 |
| 52 Week High 1.76 | 52 Week Low 0.04 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| LBPSW Daily Charts |
LBPSW Intraday Charts |
Whats New @ Bazaartrend |
LBPSW Free Analysis |
|
|
LBPSW Important Levels Intraday
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
LBPSW Forecast April 2024
| 4th UP Forecast | 1.37 |
| 3rd UP Forecast | 0.94 |
| 2nd UP Forecast | 0.68 |
| 1st UP Forecast | 0.42 |
| 1st DOWN Forecast | -0.34 |
| 2nd DOWN Forecast | -0.6 |
| 3rd DOWN Forecast | -0.86 |
| 4th DOWN Forecast | -1.29 |
LBPSW Weekly Forecast
| 4th UP Forecast | 1.00 |
| 3rd UP Forecast | 0.69 |
| 2nd UP Forecast | 0.50 |
| 1st UP Forecast | 0.31 |
| 1st DOWN Forecast | -0.23 |
| 2nd DOWN Forecast | -0.42 |
| 3rd DOWN Forecast | -0.61 |
| 4th DOWN Forecast | -0.92 |
LBPSW Forecast2024
| 4th UP Forecast | 3.35 |
| 3rd UP Forecast | 2.29 |
| 2nd UP Forecast | 1.63 |
| 1st UP Forecast | 0.98 |
| 1st DOWN Forecast | -0.9 |
| 2nd DOWN Forecast | -1.55 |
| 3rd DOWN Forecast | -2.21 |
| 4th DOWN Forecast | -3.27 |
4D pharma plc ( NASDAQ USA Symbol : LBPSW )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
LBPSW Business Profile
4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company develops therapeutic candidates, such as MRx0518; MRx-4DP000 for the treatment of asthma and COVID-19; MRx0029 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix for pediatric crohn's disease. It also develops products candidates, including MRx1299 for solid tumors, MRx0005 for neurodegeneration, MRx0006 for rheumatoid arthritis, and MRx0002 for multiple sclerosis. The company develops MicroRx platform to discover new LBP candidates for major diseases. 4D pharma plc has a collaboration agreement with Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda and MRx0518 in patients with solid tumors. The company was formerly known as Schosween 18 Limited. 4D pharma plc was incorporated in 2014 and is headquartered in Leeds, the United Kingdom. Address: 9 Bond Court, Leeds, United Kingdom, LS1 2JZ
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service